A detailed history of Nomura Asset Management CO LTD transactions in Merck & Co., Inc. stock. As of the latest transaction made, Nomura Asset Management CO LTD holds 1,236,850 shares of MRK stock, worth $141 Million. This represents 0.53% of its overall portfolio holdings.

Number of Shares
1,236,850
Previous 1,234,039 0.23%
Holding current value
$141 Million
Previous $163 Million 5.96%
% of portfolio
0.53%
Previous 0.6%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$123.8 - $132.96 $348,001 - $373,750
2,811 Added 0.23%
1,236,850 $153 Million
Q1 2024

May 13, 2024

BUY
$113.24 - $131.95 $7.81 Million - $9.1 Million
68,953 Added 5.92%
1,234,039 $163 Million
Q4 2023

Feb 09, 2024

BUY
$100.18 - $109.02 $2.97 Million - $3.24 Million
29,674 Added 2.61%
1,165,086 $127 Million
Q3 2023

Nov 03, 2023

SELL
$102.95 - $114.33 $8.26 Million - $9.17 Million
-80,214 Reduced 6.6%
1,135,412 $117 Million
Q2 2023

Aug 14, 2023

SELL
$108.61 - $118.38 $387,737 - $422,616
-3,570 Reduced 0.29%
1,215,626 $140 Million
Q1 2023

May 11, 2023

BUY
$102.94 - $114.86 $11.4 Million - $12.7 Million
110,835 Added 10.0%
1,219,196 $130 Million
Q4 2022

Feb 14, 2023

BUY
$87.44 - $112.11 $2.32 Million - $2.97 Million
26,491 Added 2.45%
1,108,361 $123 Million
Q3 2022

Nov 10, 2022

BUY
$84.53 - $94.96 $414,197 - $465,303
4,900 Added 0.45%
1,081,870 $93.2 Million
Q2 2022

Aug 12, 2022

BUY
$83.49 - $94.64 $22.9 Million - $26 Million
274,635 Added 34.23%
1,076,970 $98.2 Million
Q1 2022

May 13, 2022

BUY
$73.51 - $82.4 $69,393 - $77,785
944 Added 0.12%
802,335 $65.8 Million
Q4 2021

Feb 01, 2022

SELL
$72.28 - $90.54 $1.2 Million - $1.5 Million
-16,600 Reduced 2.03%
801,391 $61.4 Million
Q3 2021

Nov 12, 2021

SELL
$71.68 - $78.83 $2.33 Million - $2.56 Million
-32,493 Reduced 3.82%
817,991 $61.4 Million
Q2 2021

Aug 06, 2021

SELL
$70.31 - $77.77 $5.78 Million - $6.39 Million
-82,181 Reduced 8.81%
850,484 $66.1 Million
Q1 2021

May 14, 2021

SELL
$68.86 - $81.11 $21.8 Million - $25.7 Million
-316,929 Reduced 25.36%
932,665 $71.9 Million
Q4 2020

Feb 12, 2021

BUY
$71.77 - $79.65 $8.34 Million - $9.26 Million
116,269 Added 10.26%
1,249,594 $102 Million
Q3 2020

Nov 12, 2020

SELL
$73.18 - $82.95 $6.42 Million - $7.28 Million
-87,797 Reduced 7.19%
1,133,325 $94 Million
Q2 2020

Aug 13, 2020

SELL
$70.42 - $80.13 $4.3 Million - $4.89 Million
-61,039 Reduced 4.76%
1,221,122 $94.4 Million
Q1 2020

May 14, 2020

BUY
$63.36 - $87.82 $8.84 Million - $12.3 Million
139,508 Added 12.21%
1,282,161 $98.7 Million
Q4 2019

Feb 13, 2020

BUY
$77.58 - $87.54 $150,117 - $169,389
1,935 Added 0.17%
1,142,653 $104 Million
Q3 2019

Nov 13, 2019

BUY
$76.08 - $82.93 $3.23 Million - $3.52 Million
42,435 Added 3.86%
1,140,718 $96 Million
Q2 2019

Aug 13, 2019

SELL
$69.84 - $81.59 $42.8 Million - $50 Million
-612,586 Reduced 35.81%
1,098,283 $92.1 Million
Q1 2019

May 10, 2019

SELL
$69.58 - $79.36 $8.81 Million - $10.1 Million
-126,639 Reduced 6.89%
1,710,869 $142 Million
Q4 2018

Feb 12, 2019

BUY
$65.24 - $75.71 $20.3 Million - $23.6 Million
311,732 Added 20.43%
1,837,508 $140 Million
Q3 2018

Nov 07, 2018

BUY
$57.69 - $67.84 $16.3 Million - $19.2 Million
282,695 Added 22.74%
1,525,776 $108 Million
Q2 2018

Aug 03, 2018

BUY
$50.83 - $59.72 $101,355 - $119,081
1,994 Added 0.16%
1,243,081 $75.5 Million
Q1 2018

May 14, 2018

BUY
$50.96 - $59.23 $1.26 Million - $1.47 Million
24,777 Added 2.04%
1,241,087 $67.6 Million
Q4 2017

Feb 14, 2018

BUY
$51.62 - $61.64 $4.38 Million - $5.24 Million
84,945 Added 7.51%
1,216,310 $68.4 Million
Q3 2017

Nov 13, 2017

BUY
$58.67 - $63.13 $35.9 Million - $38.7 Million
612,429 Added 118.02%
1,131,365 $72.4 Million
Q2 2017

Aug 14, 2017

BUY
N/A
518,936
518,936 $33.3 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $288B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Nomura Asset Management CO LTD Portfolio

Follow Nomura Asset Management CO LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Asset Management CO LTD, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Asset Management CO LTD with notifications on news.